stdClass Object ( [id] => 8302 [paper_index] => EW201708-01-002018 [title] => DOCTORS PERSPECTIVE ON THE POSITIONING STRATEGIES ADOPTED BY THE PHARMACEUTICAL COMPANIES [description] =>
  1. Lal, A. Moharana, A. K. Chandra, P. Ray, A. (2001) Critical evaluation of references in drug advertisements: an Indian experience. Journal of the Association of Physicians of India 1996; 44:778-779.
  2. Kalantri SP. (2004) Letter from Sevagram: The Eleven billion dollar question. Issues in Medical Ethics 2002; 10: 78.
[author] => Ms.A.K.Vageetha [googlescholar] => https://scholar.google.co.in/citations?view_op=view_citation&hl=en&user=KeqZGcIAAAAJ&cstart=20&pagesize=80&imq=EPRA+International+Journal+of+Economic+and+Business+Review&citation_for_view=KeqZGcIAAAAJ:ubry08Y2EpUC [doi] => [year] => 2017 [month] => September [volume] => 5 [issue] => 9 [file] => eprapub/EW201708-01-002018.pdf [abstract] =>

The Indian pharmaceuticals market is the third largest in terms of volume and thirteenth largest in terms of value, as per a report by Equity Master. Branded generics dominate the pharmaceuticals market, consisting nearly 70 to 80 percent of the market. India enjoys an important position in the global pharmaceuticals sector. According to India ratings, a Fitch company, the Indian pharmaceutical industry is estimated to grow at 20 percent Compound Annual Growth Rate (CAGR) over the next five years. As on march 2014, the market size of the pharmaceutical industry in India stands at US $ 20 billion.

KEYWORDS: Pharmaceuticals, market size, Doctors, branded medicine

[keywords] => [doj] => [hit] => 1774 [status] => [award_status] => P [orderr] => 2 [journal_id] => 4 [googlesearch_link] => [edit_on] => [is_status] => 1 [journalname] => EPRA International Journal of Economic and Business Review(JEBR) [short_code] => IJES [eissn] => 2347-9671 (O), 2349-0187(P) [pissn] => [home_page_wrapper] => images/products_image/12.JEBR.png ) Error fetching PDF file.